The Definition of ABO Factors in Transplantation: Relation to Other Humoral Antibody States
Overview
Affiliations
The first examples of hyperacute rejection of renal hemografts were seen almost 25 years ago when kidneys were transplanted to ABO incompatible recipients whose plasma contained antigraft isoagglutinins. Hyperacute rejection caused in sensitized recipients by lymphocytotoxic antibodies is similar in that the immune reaction triggers an acute inflammatory reaction that leads to widespread thrombotic occlusion and devascularization of the graft. The events after xenotransplantation between certain species are essentially the same. Potential strategies to avoid the precipitating antigen antibody reaction or to mitigate the resulting effector cascade are described.
Latest insights on ABO-incompatible living-donor renal transplantation.
Uchida J, Kosoku A, Naganuma T, Tanaka T, Nakatani T Int J Urol. 2019; 27(1):30-38.
PMID: 31522462 PMC: 7004137. DOI: 10.1111/iju.14109.
Strategies to overcome the ABO barrier in kidney transplantation.
Bohmig G, Farkas A, Eskandary F, Wekerle T Nat Rev Nephrol. 2015; 11(12):732-47.
PMID: 26324199 DOI: 10.1038/nrneph.2015.144.
Wang D, Quan Y, Yan Q, Morales J, Wetsel R Stem Cells Transl Med. 2015; 4(10):1234-45.
PMID: 26285657 PMC: 4572902. DOI: 10.5966/sctm.2015-0049.
The Future of Xenotransplantation.
Starzl T Ann Surg. 2014; 216(4):3-10.
PMID: 25006273 PMC: 4082968.
Human liver xenotransplantation.
Starzl T, Tzakis A, Fung J, Todo S, Marino I, Demetris A Xeno. 2011; 1(1):4-7.
PMID: 21785753 PMC: 3141328.